HIV/AIDS Research Highlights Need for Improved HCV Treatment and Prevention Strategies

Strategic Insights -

Research conducted at Yale University School of Medicine, in collaboration with seven diverse health department jurisdictions, has demonstrated the importance of addressing the needs of individuals coinfected with HIV and HCV. The study, published in Open Forum Infectious Diseases, highlights the benefits of direct-acting antivirals (DAAs) in achieving viral cure targets and emphasizes the critical role of HIV care engagement in improving HCV outcomes. Key findings from the study include significantly lower odds of viral cure among Black/African American individuals compared to White individuals, as well as improved HCV outcomes among those with HIV viral suppression.

Key Takeaways:

  • The study revealed that 31.6% of coinfected individuals achieved viral cure/clearance at baseline, increasing to 42.4% at the study's end.
  • The Centers for Disease Control and Prevention HCV clearance cascade was implemented in 7 health department jurisdictions, resulting in improved HCV outcomes.
  • Men who have sex with men exhibited significantly higher odds of viral cure/clearance compared to heterosexuals.
  • HIV viral suppression was associated with improved HCV outcomes, indicating the importance of coordinated HIV care engagement.
  • The study emphasizes the need for public health strategies that address the unique needs of coinfected individuals and leverage existing clinical and public health infrastructure for HIV.

Statistics:

  • 31.6% of coinfected individuals achieved viral cure/clearance at baseline (Source: Open Forum Infectious Diseases).
  • 42.4% of coinfected individuals achieved viral cure/clearance at the study's end (Source: Open Forum Infectious Diseases).
  • Black/African American individuals exhibited significantly lower odds of viral cure/clearance compared to White individuals (adjusted odds ratio [aOR], 0.83; P = .03).
  • Men who have sex with men exhibited significantly higher odds of viral cure/clearance compared to heterosexuals (aOR, 1.46; P = .004).
  • HIV viral suppression was associated with improved HCV outcomes (aOR, 2.19; P = .008).

Sources:

  • Open Forum Infectious Diseases, 2025;12(8).
  • Oxford Univ Press Inc, Journals Dept, 2001 Evans Rd, Cary, NC 27513, USA (contact information for Open Forum Infectious Diseases).
  • Maximilian Wegener, Yale University School of Medicine, Dept. of Internal Medicine, HIV/AIDS Program, Section of Infectious Diseases, 135 Coll St, Ste 323, New Haven, CT 06510, United States (corresponding author).
  • Ralph Brooks, Lisa Nichols, Frederick L. Altice, and Merceditas Villanueva (additional authors).